Home » News from the Brain Interchange Development

News from the Brain Interchange Development

We continue to make progress in the development of our Brain Interchange System. We recently completed our pre-clinical testing and key development milestones.  In the next phase of development, we will further refine our technology, and enter the final stages of preparation for our First-in-Human clinical studies.

As the Brain Interchange System enters the next phase, we look forward to collaborating with our U.S. clinical partners to study this novel technology in the treatment of neurogenerative and disabling neurological conditions, disorders, and diseases with unmet or suboptimal clinical solutions.

Claus Freyinger, Chief Regulatory & Clinical Officer of CorTec, says: “We continue to make progress with our pre-clinical work. We remain convinced that the Brain Interchange System is an extremely promising technology to address unmet clinical needs in areas such as stroke rehabilitation, epilepsy, and chronic pain. ”

With our plans and milestones in mind, we will of course provide you with further information on our progress. At INS in Barcelona next month, we will be presenting more details about Brain Interchange and the evaluation kit in several scientific poster sessions.

We look forward to sharing more great news with you – make sure to follow us on LinkedIn to join us on our journey!




May 13, 2022

CorTec awarded with second place of the 2021 Future Prize

April 15, 2022

Easter Surprise from CorTec!

April 11, 2022

Bernstein-CorTec Award 2022

March 22, 2022

CorTec strengthens Executive Leadership Team and Advisory Board

January 5, 2022

Meet us at NANS!

November 18, 2021

Compamed 2021 | Last chance to meet us!

November 11, 2021

SfN Countdown – Visit us!

November 9, 2021

Visit us at SfN 2021